Related Experiment Videos
[7/8th pancreas resection in nesidioblastosis?]
H P Hümmer1, H Böhles, J Giedl
1Kinderchirurgische Abteilung, Universitäts-Kinderklinik Erlangen.
Summary
The extent of pancreatectomy for nesidioblastosis treatment is debated. Extensive resection in infants with nesidioblastosis can lead to positive outcomes, suggesting prognosis depends on initial surgical extent.
Area of Science:
- Pediatric surgery
- Endocrinology
- Gastroenterology
Background:
- Nesidioblastosis is a rare condition characterized by abnormal pancreatic islet cell proliferation.
- Treatment for nesidioblastosis, particularly the extent of pancreatectomy, remains a subject of clinical debate.
- Potential complications include recurrent hypoglycemia, insulin-dependent diabetes mellitus, and exocrine insufficiency.
Observation:
- Two infant cases of nesidioblastosis are presented.
- Case 1: A 13-month-old female underwent a 7/8 pancreatectomy for multifocal adenomatosis.
- Case 2: A 7-month-old male had a 95% pancreatic resection, including the uncinate process, for focal adenomatosis and diffuse nesidioblastosis.
Findings:
- Both patients remained asymptomatic post-surgery.
- Both patients achieved and maintained normoglycemia without further hypoglycemic episodes.
Implications:
- Extensive pancreatic resection in infants with nesidioblastosis appears to be a safe and effective treatment.
- The degree of initial resection is a critical factor influencing the long-term prognosis for patients with nesidioblastosis.
- These findings support aggressive surgical management in select cases of pediatric nesidioblastosis.